Károly Tόth

Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α

Y. Rustum, R. Jensen, S. Cao, 2010, Cancer Chemotherapy and Pharmacology.